In the presentstudy, we sought to provide insight into the functional and regulatorycharacteristics of cyclin D1, to determine its potential as a therapeutic target forglioblastoma, and to evaluate whether the expression of cyclin D1 is associated withclinical and pathological features in glioblastoma. The gene discussed is CCND1; the disease is glioblastoma.